Ferticility care awards
Contact
EN
  • HR
  • IT
  • Contact
  • ASSISTED REPRODUCTION

    ABOUT ASSISTED REPRODUCTION

    • Assisted reproduction
    • Diagnosis and treatment of infertility
    • Preparation for AR
    • FAQ
    • Legal regulations
    • Glossary of terms

    INFERTILITY

    • Infertility in women
    • Infertility in men
    • Spermiogram
    • Prevention of OHSS
    • Combination protocols
    • PCOS

    METHODS OF ASSISTED REPRODUCTION

    • Cycle management
    • Stimulation protocols
    • IUI insemination
    • IVF/ICSI
    • CryoET

    LABORATORY PROCEDURES

    • IVF/ICSI
    • PICSI
    • Sperm DNA fragmentation
    • Determination of oxidative stress in ejaculate
    • Cryopreservation of semen
    • Vitrification of embryos and oocytes
    • Social freezing for cancer patients
    • Freeze all technology
    • TESE, TESA, PESA
    • EmbryoGlue
  • GYNECOLOGY AND OBSTETRICS

    GYNECOLOGY AND OBSTETRICS

    • Gynecology and pregnancy
    • Advanced ultrasound diagnostics
    • Gynecological endocrinology and PCOS
    • Pathology of the uterus
    • Endometriosis
    • Menopause
    • Gynecology for young people
    • Family planning and contraception
  • HYSTEROSCOPY

    HYSTEROSCOPY

    • Outpatient hysteroscopy
    • Outpatient hysteroscopy - instructions for patients
  • MIA polyclinic

    MIA polyclinic

    • Contacts and working hours
    • MIA polyclinic
    • PRONATAL and MIA polyclinic
    • Media contact
    • Expert Council
Sperm DNA fragmentation

Sperm DNA fragmentation

Sperm DNA fragmentation

New embryological tests for sperm abnormalities

The new embryological tests for sperm abnormalities - with DNA fragmentation - are a kind of male fertility test that measures the amount of damaged DNA in a sperm sample. Essentially, all men have damaged sperm DNA, and milder disruptions in the sperm genome are sometimes corrected by the egg cell (or embryo) after fertilization. This is not possible with significant sperm DNA defects, and fertilization will be missed, implantation will be impaired, or early subclinical miscarriage will occur.

The described diagnostic approach has been successfully applied in the laboratory of the MIA Polyclinic. It allows for significantly improved IVF and a focus on more successful treatment supplementation.

Male infertility

Member of the PRONATAL Group

The PRONATAL Group with its 11 centers is a European leader in the field of reproductive medicine and assisted reproduction.

Contact

  • Group 3 Zametska 13, Rijeka
  • Group 4 +385 51 309 950
  • Group 3 info@miapoliklinika.hr

Opening hours

  • Group 5 Monday - Thursday  8.00 - 20.00
      Friday  8.00 - 16.00
      Saturday 8.00 - 13.00

Important links

  • Infertility treatment
  • Artificial insemination
  • Glosary of terms
  • Certificates and annual reports
  • Information for patients
  • Contact
  • Price list
  • MIA
Write to us
Copyright © 2025 PRONATAL. Member of MEDICON Group | Cookies settings
Made by Brandmark Boutique & Apploud Digital